Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.

Aubry-Rozier, B; Gonzalez-Rodriguez, E; Stoll, D; Lamy, O

Aubry-Rozier, B; Gonzalez-Rodriguez, E; Stoll, D; Lamy, O.

Affiliation

Aubry-Rozier B; Center of Bone Diseases, Bone and Joint Department, Lausanne University Hospital, Av. Pierre-Decker 4, 1011, Lausanne, Switzerland. berengere.aubry@chuv.ch.
Gonzalez-Rodriguez E; Center of Bone Diseases, Bone and Joint Department, Lausanne University Hospital, Av. Pierre-Decker 4, 1011, Lausanne, Switzerland.
Stoll D; Center of Bone Diseases, Bone and Joint Department, Lausanne University Hospital, Av. Pierre-Decker 4, 1011, Lausanne, Switzerland.
Lamy O; Center of Bone Diseases, Bone and Joint Department, Lausanne University Hospital, Av. Pierre-Decker 4, 1011, Lausanne, Switzerland.

Osteoporos Int ; 27(5): 1923-5, 2016 May.

Article in En | MEDLINE | ID: mdl-26510845

Subject(s)

Bone Density Conservation Agents/administration & dosage; Denosumab/administration & dosage; Fractures, Spontaneous/etiology; Osteoporotic Fractures/etiology; Spinal Fractures/etiology; Aged; Bone Density Conservation Agents/therapeutic use; Denosumab/therapeutic use; Drug Administration Schedule; Female; Fractures, Spontaneous/prevention & control; Humans; Middle Aged; Osteoporosis, Postmenopausal/complications; Osteoporosis, Postmenopausal/drug therapy; Osteoporotic Fractures/prevention & control; Spinal Fractures/prevention & control; Withholding Treatment

Key words

Denosumab discontinuation; Osteoporotic fracture; Osteoporotic treatment duration

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spinal Fractures / Bone Density Conservation Agents / Osteoporotic Fractures / Denosumab / Fractures, Spontaneous Limits: Aged / Female / Humans / Middle aged Language: En Journal: Osteoporos Int Year: 2016 Document type: Article

Fulltext

XML

PubMed Links

Search on Google